Replies to post #1244 on GTC Biotherapeutics (fka GTCB)

[urche]

insider ownership

Sounds like I stand corrected. Thanks for pointing out my error, Symboltech and thanks, Dew, for the additional data.

To summarize, disregarding the options, some of which are apparently included in the figures on insider ownership in the 2006 proxy statement, we can count on insider ownership in the range of 5%. I agree that is uninspiring and disappointing.

Urche.